20:00 Start and welcome (Enrico Robotti)

20:05-20:15 Prof Parham Sendi, lecture “C-19 PCR and Antibody test”.

20:15-20:23 Session 1: Protection during consultation with patients

Chair: Philio Lekakis

• • Separate COVID-19 area in private practice?
  • Which items work – masks, shields, air purifying systems, UV-C, disinfection?
  • How to use them?
  • Chest CT scan for screen or diagnosis?

20:23-20:30 Discussion, consensus conference with voting by expert panel, Q&A

20:30-20:40 Rod Rohrich “How do we handle this in Dallas and how the situation is seen and evolves in the US Plastic Surgery community”

20:40-20:50  Session 2: Patient assessment Pre-Op

Chair: Charles East

Patient selection, indication:        

• • Structured medical history: What are the key questions?
  • Which patients should not undergo surgery?
  • Which operations can/may/should be performed?
  • Operation indications? (elective is not elective)

Testing:        

• • How to avoid operating on undetected COVID-19 patients
  • Which PCR test?
  • Are Antibody-tests useful at the moment?

Timing:          

• • How many days/hours before operation?
  • Is quarantine necessary? Duration?

20:50-21:00 Discussion, consensus conference with voting by expert panel, Q&A

21:00-21:05 Sam Most “How do we handle this at Stanford and how the situation is seen and evolves in the US ENT community”

21:05-21:15 Session 3: Intra-Op

Chair: Werner Heppt, Olivier Gerbault

• • Is an antiseptic packing prior to surgery of any use to reduce the viral charge? 
  • Intranasal/pharynx disinfection? How and which products? 
  • Does laminar flow protect us? 
  • How to protect ourselves?
  • General anesthesia: Is there a difference? 
  • Aerosol in the OR: How to avoid production? 
  • Are there techniques/maneuvers to avoid? Power instruments ? Piezo? 
  • Nasal packing: How to handle? 

21:15-21:25 Discussion, consensus conference with voting by expert panel, Q&A

21:25-21:30 Mario Bussi “Italian ENT Society and other European ENT Societies good practice perspectives regarding rhinoplasty in the COVID-19 era”

21:30-21:40 Jay Calvert “Performing rhinoplasty safely during the COVID-19 pandemic: a perspective from The Rhinoplasty Society US”

21:40-21:45 Rod Rohrich “Medical rhinoplasty and fillers: How should we approach it?”

21:45-21:50 Sam Most “Surviving COVID-19, perspectives from the other side: as a patient”

21:50-22:00 Session 4: Legal aspects, problems

Chair: Haldun Kamburoglu

• • Does COVID-19 influence the rate of problems during surgery?
  • How can a rhinoplasty patient be infected (consultation, operation, follow-up) and in which circumstances is the surgeon responsible?
  • Is this a complication or malpractice?
  • What is the correct timing for resuming elective surgery? Is it worth to take the risk? What should be the threshold – corona virus positive cases number in your city to feel safe?
  • Do informed consent forms protect us?
  • If any risk occurs, does your insurance policy cover it?

22:00 Discussion, consensus conference with voting by expert panel, Q&A

Conclusions by Martin Haug, Enrico Robotti